Health insurer Cigna (CI) reported a surge in its second-quarter profit and revenue, mainly due to strong performance across multiple businesses. The company also raised its full-year 2018 outlook that sent the stock up 2.22%.
Cigna’s revenue rose 10% to $11.5 billion, topping the consensus estimate of $11.15 billion.
Net income was $806 million, or $3.29 per share, compared to $813 million, or $3.15 per share, for the second quarter of 2017. Excluding items, the health service company earned $3.89 per share, that beat consensus estimate of $3.33 per share.
“Our strong second quarter results once again reflect the consistent effective execution of our global strategy, which will be further enhanced through our pending combination with Express Scripts.” said David M. Cordani, CEO.
Cigna’s medical customer base at the end of Q2 2018 totaled 16.2 million, an increase of 329,000 customers year to date. This increase was driven by continued organic growth in Select, Middle Market, and Individual segments.
The company reported Total Commercial medical care ratio (“MCR”) of 76.3%, reflecting the strong performance Commercial Employer business, the pricing effect of the resumption of the health insurance tax, and favorable prior-year reserve development.
For fiscal 2018, adjusted EPS is projected to grow to $13.60 to 13.90.
Related Infographic
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was